- Home
- BWBBP vs NVRO Comparison
BWBBP vs NVRO Comparison
Compare BWBBP & NVRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWBBP
- NVRO
- Stock Information
- Founded
- BWBBP N/A
- NVRO 2006
- Country
- BWBBP United States
- NVRO United States
- Employees
- BWBBP 258
- NVRO N/A
- Industry
- BWBBP Major Banks
- NVRO Medical/Dental Instruments
- Sector
- BWBBP Finance
- NVRO Health Care
- Exchange
- BWBBP Nasdaq
- NVRO Nasdaq
- Market Cap
- BWBBP N/A
- NVRO 134.5M
- IPO Year
- BWBBP N/A
- NVRO 2014
- Fundamental
- Price
- BWBBP $20.04
- NVRO $3.71
- Analyst Decision
- BWBBP
- NVRO Hold
- Analyst Count
- BWBBP 0
- NVRO 14
- Target Price
- BWBBP N/A
- NVRO $7.97
- AVG Volume (30 Days)
- BWBBP N/A
- NVRO 395.4K
- Earning Date
- BWBBP N/A
- NVRO 02-19-2025
- Dividend Yield
- BWBBP N/A
- NVRO N/A
- EPS Growth
- BWBBP N/A
- NVRO N/A
- EPS
- BWBBP N/A
- NVRO N/A
- Revenue
- BWBBP N/A
- NVRO $419,146,000.00
- Revenue This Year
- BWBBP N/A
- NVRO N/A
- Revenue Next Year
- BWBBP N/A
- NVRO $0.65
- P/E Ratio
- BWBBP N/A
- NVRO N/A
- Revenue Growth
- BWBBP N/A
- NVRO N/A
- 52 Week Low
- BWBBP N/A
- NVRO $3.52
- 52 Week High
- BWBBP N/A
- NVRO $21.66
- Technical
- Relative Strength Index (RSI)
- BWBBP 60.55
- NVRO 38.60
- Support Level
- BWBBP $18.56
- NVRO $3.60
- Resistance Level
- BWBBP $19.00
- NVRO $3.90
- Average True Range (ATR)
- BWBBP 0.60
- NVRO 0.29
- MACD
- BWBBP 0.17
- NVRO 0.00
- Stochastic Oscillator
- BWBBP 68.33
- NVRO 20.88
About BWBBP Bridgewater Bancshares Inc. Depositary Shares Each Representing a 1/100th Interest in a Share of 5.875% Non-Cumulative Perpetual Preferred Stock Series A
Bridgewater Bancshares Inc offers retail and commercial loan and deposit services to customers within the Minneapolis-St. Paul-Bloomington, MN-WI Metropolitan Statistical Area. The company engages in providing a wide range of deposit and lending products. Its products and services include commercial deposits, loans, online business services, credit card, mobile banking, and remote deposit services.
About NVRO Nevro Corp.
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.